CLINICAL CENTER FOR CAMP

首要目标 为了确定在5-9岁患有哮喘的儿童中， 定期使用两类消炎药中的任何一种 (吸入皮质类固醇或色甘酸钠)，与常规 支气管扩张剂的用药和相互作用，会导致更大的肺 功能和较少的支气管高反应性在五年期间。 次要目标 以确定这两种抗炎药物中是否有一种与 支气管扩张剂的用药和相互作用，导致患者减少 发病率，以症状频度、活动受限天数、 还有失学的日子。 以确定这两种抗炎药物中是否有一种与 常规的支气管扩张剂药物和相互之间的相互作用导致较少使用 医疗保健资源，如急诊室就诊或 住院治疗。 比较这两类药物的长期安全性和副作用。 抗炎药物，与支气管扩张剂药物和 为了彼此。 比较两类抗炎药的抗炎效果 药物与支气管扩张剂药物以及彼此之间的比较，关于 身体和心理社会发展，以及生活质量。

Primary Objective To determine, in a population of 5-9 year old children with asthma, if regular use of either of two classes of anti-inflammatory medications (inhaled corticosteroids or cromolyn sodium), compared to regular bronchodilator medication and to each other, results in greater lung function and less bronchial hyperresponsiveness over a five year period. Secondary Objectives To determine if either of the anti-inflammatory medications, compared to bronchodilator medication and to each other, results in less patient morbidity, measured by frequency of symptoms, days of limited activity, and days lost from school. To determine if either of the anti-inflammatory medications compared to regular bronchodilator medication and to each other results in less use of health care resources such as emergency room visits or hospitalizations. To compare the long term safety and side effects of the two classes of anti-inflammatory medications, compared to bronchodilator medication and to each other. To compare the effects of the two classes of anti-inflammatory medications, compared to bronchodilator medication and to each other, on physical and psychosocial development, and quality of life.